Griguolo, Gaia http://orcid.org/0000-0002-8782-4509
Dieci, Maria Vittoria http://orcid.org/0000-0002-3967-9861
Paré, Laia http://orcid.org/0000-0002-4904-558X
Miglietta, Federica
Generali, Daniele Giulio
Frassoldati, Antonio
Cavanna, Luigi
Bisagni, Giancarlo
Piacentini, Federico http://orcid.org/0000-0001-8969-638X
Tagliafico, Enrico
Cagossi, Katia
Ficarra, Guido
Prat, Aleix http://orcid.org/0000-0003-2377-540X
Conte, Pierfranco
Guarneri, Valentina
Article History
Received: 24 July 2020
Accepted: 13 January 2021
First Online: 12 February 2021
Competing interests
: M.V.D. reports personal fees from Genomic Health, EliLilly, and Celgene, outside the submitted work. A.F. reports personal fees from Roche, Novartis, and Pfizer, outside the submitted work. F.P. reports personal fees from Eisai, outside the submitted work. A.P. reports consulting fees from Nanostring Technologies, Roche, Pfizer, Oncolytics Biotech, Puma, Lilly, AstraZeneca, Seattle Genetics, Novartis, Amgen, B.M.S., M.S.D. and Daiichi Sankyo outside the submitted work. P.F.C. reports grants (Institution) from Merck KGa, Bristol-Myers Squibb, Novartis, Roche; personal fees from Novartis, EliLilly, AstraZeneca, Tesaro, B.M.S., Roche and Daiichi Sankyo outside the submitted work. V.G. reports grants (Institution) from Roche; personal fees from Novartis, Roche, and Eli Lilly, outside the submitted work. All other authors have nothing to disclose.